MOLECULAR STUDY THE COMBINATION OF JBJ-04-125-02 AND OSIMERTINIB AS INHIBITORS OF DOUBLE MUTANT (T790M/V948R) AND TRIPLE MUTANT (T790M/C797S/V948R) EGFR MUTANTS AT ALLOSTERIC SITES AND ATP SITES
The most common type of lung cancer is the Non-Small Cell Lung Cancer (NSCLC) type, accounting for 80-85% of the total lung cancer sufferers in the world. Epidermal Growth Factor Receptor - Tyrosine Kinase Inhibitor (EGFR-TKI) is recommended as first-line treatment of advanced EGFR-mutant NSCL...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses |
| Language: | Indonesia |
| Online Access: | https://digilib.itb.ac.id/gdl/view/76566 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Institut Teknologi Bandung |
| Language: | Indonesia |